4Degen E. Efficient dissociation of the p88 chaperone from major histocompatibility complex class Ⅰ molecules reguires both B2 - Microglobulin and peptide[J]. J Exp Med,1992, 175(10) :1653.
5Jacques JN. Cell biology of antigen prosentation in [J]. Curt Opin Immunol, 1993,5(1) :27.
6Anderson NS, Milier J. lnvariant chain can function as chaperone protein for class major histocompatibility complex molecules [J]. Prol Natl Acad Sic USA, 1998, 89(20) : 2282.
7Okada H,Tahara H,Shurin MR et al. Bone marrow - derived dendritic cells pulsed with a tumor - specific peptide elicit effective anti - tumor immunity against intracranial neoplasms[J]. lnt J Cancer, 2000, 78(2) :196 -201.
8Labarriwere N. Apoptotic body - loaded dendritic cells efficiently cross - prime ytotoxicT lymphocytes specific for NA17 - A antigen but not for Melan - A/MART - Intigen[J]. Int Cancer 2002,101(3) : 280.
9Gong JL. Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide(280 - 288 ), induce pairs of T - cell cultures with similar phenotype and lytic activity[J]. Cell lmmunol, 2000,186(1): 63.
10Coa X, Zhang W, Wang J, et al. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte - macrophage colony - stimulating factor genetically modified dendritic cells[J]. Immunology, 1999, 97(4) :616.
